K-ras mutations and cetuximab in colorectal cancer.
Codacci-Pisanelli
Giovanni
G
Spinelli
Gianpaolo
G
Tomao
Silverio
S
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality; D018450:Disease Progression; D011905:Genes, ras; D006801:Humans; D009154:Mutation; D016019:Survival Analysis
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab